Purification of Adipose Tissue Mesenchymal Stem Cells and Differentiation Toward Hepatic-Like Cells

  • Agnieszka BanasEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 826)


There is a great interest in the development of functional hepatocytes in vitro from different types of stem cells. Multipotential mesenchymal stem cells (MSC) compose a great source for stem cell based therapy, especially, because they can be obtain from patients own tissues, sidestepping immunocompatibility and ethical issues. Among MSCs from different sources, adipose-tissue-derived mesenchymal stem cells (AT-MSCs) are very promising because of their high accessibility, proliferation ability, potentiality, and immunocompatibility.

AT-MSCs can be easily isolated from stroma vascular fraction (SVF) of adipose tissue. They represent a heterogeneous population of cells. The precise AT-MSCs’s marker profile has not been defined yet; therefore, it is still not obvious how to purify these heterogeneous fraction of cells. We postulate that one of the markers defining MSC provenance is CD105 (endoglin).

Therefore, we have sorted CD105+ fraction of AT-MSCs, expanded them, and differentiated toward hepatic-like cells. In order to check their potentiality, we have firstly differentiated sorted CD105+ AT-MSCs toward mesoderm lineages, using commercialized protocols.

We have shown here, that pure CD105+ AT-MSCs fraction revealed higher homogeneity and differentiation potential toward adipogenic, osteogenic, and chondrogenic lineages and highly inducible into the hepatogenic lineage.

Generated (by using our hepatic differentiation protocol) CD105+ AT-MSCs-derived hepatic-like cells expressed hepatocyte markers, enzymes, and functions.

Key words

Mesenchymal stem cells Adipose-tissue-derived mesenchymal stem cells Adipose tissue Liver disease Liver regeneration Plasticity Differentiation 



We would like to thank Dr. Satoshi Suzuki (Human and Animal Bridging Research Organization), Dr. Kazunori Aoki, Ms. Nachi Namatame, Ms. Shinobu Ueda, Dr. Akihiro Kobayashi, Ms. Ayako Inoue, Fumitaka Takeshita, and Ms. Maho Kodama (National Cancer Center Research Institute) for their valuable advice and assistance. This work was supported in part by a Grant-in-Aid for the Third-Term Comprehensive 10-year Strategy for Cancer Control; Health Science Research Grants for Research on the Human Genome and Regenerative Medicine from the Ministry of Health, Labor, and Welfare of Japan; and a Grant from Japan Health Sciences Foundation.


  1. 1.
    Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., Alfonso Z.C., et al. (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13, 4279–4295.PubMedCrossRefGoogle Scholar
  2. 2.
    Strem B.M., Hicok K.C., Zhu M., Wulur I., Alfonso Z.C., Schreiber R.E., Fraser J.K., et al. (2005) Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 54, 132–141.PubMedCrossRefGoogle Scholar
  3. 3.
    Katz A.J., Tholpady A., Tholpady S.S., Shang H., Ogle R.C. (2005) Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 23, 412–423.PubMedCrossRefGoogle Scholar
  4. 4.
    Guilak F., Lott K.E., Awad H.A., Cao Q., Hicok K.C., Fermor B., Gimble J.M. (2006) Clonal analysis of the differentiation potential of human adipocyte-derived adult stem cells. J Cell Physiol 206, 229–237.PubMedCrossRefGoogle Scholar
  5. 5.
    Lee R.H., Kim B., Choi I., Kim H., Choi H.S., Suh K., Bae Y.C., et al. (2004) Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14, 311–324.PubMedCrossRefGoogle Scholar
  6. 6.
    Wagner W., Wein F., Seckinger A., Frankhauser M., Wirkner U., Krause U., Blake J., et al (2005) Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33, 1402–1416.PubMedCrossRefGoogle Scholar
  7. 7.
    Kern S., Eichler H., Stoeve J., Kluter H., Bieback K. (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood or adipose tissue. Stem Cells 24, 1294–1301.PubMedCrossRefGoogle Scholar
  8. 8.
    Boquest A.C., Shahdadfar A., Fronsdal K., Sigurjonsson O., Tunheim S.H., Collas P., Brinchmann J.E. (2005) Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol Biol Cell 16, 1131–1141.PubMedCrossRefGoogle Scholar
  9. 9.
    Pittenger M.F, Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143–147.PubMedCrossRefGoogle Scholar
  10. 10.
    Haynesworth S.E., Baber M.A., Caplan A.I. (1992) Cell surface antigens on human marrow-derived mesenchymal stem cells are detected by monoclonal antibodies. Bone 13, 69–80.PubMedCrossRefGoogle Scholar
  11. 11.
    Liu P.G., Zhou D.B., Shen T. (2005) Identification of human bone marrow mesenchymal stem cells: preparation and utilization of two monoclonal antibodies against SH2, SH3. (in Chinese) Zhongguo Shi Yan Xue Ye Xue Za Zhi 13, 656–659.PubMedGoogle Scholar
  12. 12.
    Aslan H., Zilberman Y., Kendel A., Liebergall M., Oskouian R.J., Gazit D., Gazit Z. (2006) Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells. Stem Cells 24, 1728–1737.PubMedCrossRefGoogle Scholar
  13. 13.
    Majumdar M.K., Banks V., Peluso D.P., Morris E.A. (2000) Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J Cell Physiol 185, 98–106.PubMedCrossRefGoogle Scholar
  14. 14.
    Roura S., Farre J., Soler-Botija C., Llach A, Hove-Madsen L., Cairo J.J., Godia F., et al. (2006) Effect of aging on the pluripotent capacity of human CD105+ mesenchymal stem cells. Eur J Heart Fail 8, 555–563.PubMedCrossRefGoogle Scholar
  15. 15.
    Chen C.Z., Li M., de Graaf D., Monti S., et al. (2002) Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells. Proc Natl Acad Sci USA 99, 15468–15473.PubMedCrossRefGoogle Scholar
  16. 16.
    Banas A., Teratani T., Yamamoto Y., Tokuhara M., Takeshita F., Quinn G., Okochi H., Ochiya T. (2007) Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 46, 219–228.PubMedCrossRefGoogle Scholar
  17. 17.
    Teratani T., Yamamoto H., Aoyagi K., Sasaki H., Asari A., Quinn G., Sasaki H., Terada M., Ochiya T. (2005) Direct hepatic fate specification from mouse embryonic stem cells. Hepatology 41, 836–846.PubMedCrossRefGoogle Scholar
  18. 18.
    Yamamoto Y., Teratani T., Yamamoto H., Quinn G., Murata S., Ikeda R., Kinoshita K., Matsubara K., Kato T., Ochiya T. (2005) Recapitulation of in vivo gene expression during hepatic differentiation from embryonic stem cells. Hepatology 42, 558–567.PubMedCrossRefGoogle Scholar
  19. 19.
    Yamamoto H., Quinn G., Asari A., Yamanokuchi H., Teratani T., Terada M., Ochiya T. (2003) Differentiation of embryonic stem cells into hepatocytes: biological functions and therapeutic application. Hepatology 37, 983–993.PubMedCrossRefGoogle Scholar
  20. 20.
    Banas A., Yamamoto Y., Teratani T., Ochiya T. (2007) Stem cell plasticity: Learning from hepatogenic differentiation strategies. Developmental Dynamics 236, 3228–3241.PubMedCrossRefGoogle Scholar
  21. 21.
    Banas A., Teratani T., Yamamoto Y., Tokuhara M., Takeshita F., Osaki M., Kawamata M., Kato T., Okochi H., Ochiya T. (2008) IFATS Collection: In vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 26, 2705–2712.PubMedCrossRefGoogle Scholar
  22. 22.
    Yamamoto .Y., Banas A., Murata S., Teratani T., Lim C.R., Hatada I., Matsubara K., Kato T., Ochiya T. (2008) A comparative analysis of transcriptome and signal pathway in hepatic differentiation of human adipose mesenchymal stem cells. FEBS J 275, 1260–1273.PubMedCrossRefGoogle Scholar
  23. 23.
    Ishikawa T., Banas A., Hagiwara K., Iwaguro H., Ochiya T. (2010) Stem Cells for hepatic regeneration: the role of adipose tissue derived mesenchymal stem cells. Curr Stem Cell Res Ther 5, 182–189.PubMedCrossRefGoogle Scholar
  24. 24.
    Ochiya T., Yamamoto Y., Banas A. (2010) Commitment of stem cells into functional hepatocytes. Differentiation 79, 65–73.PubMedCrossRefGoogle Scholar
  25. 25.
    Banas A., Teratani T., Yamamoto Y., Tokuhara M., Takeshita F., Osaki M., Kato T., Okochi H., Ochiya T. (2009) A rapid hepatic fate specification of adipose-derived stem cells (ASCs) and their therapeutic potential for liver failure. J Gastr Hepatol 24, 70–77.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Laboratory of Molecular Biology, Institute of Obstetrics and Medical RescueUniversity of Rzeszów, Faculty of MedicineRzeszowPoland

Personalised recommendations